Legend Biotech (LEGN) Director Corazon Sanders Receives RSU Award

What Happened
Corazon (Corsee) D. Sanders, a director of Legend Biotech (LEGN), was granted 20,986 restricted share units (RSUs) on 2026-09-24. The reported acquisition price is $0.00 (an award/grant), so no cash was paid. These RSUs are a contingent right to receive ordinary shares upon settlement rather than immediate transferable shares.

Key Details

• Transaction type/code: Award/Grant (A) — 20,986 RSUs granted on 2026-09-24 at $0.00.
• Vesting: 1/3 of the RSUs vest on December 20, 2027; the remainder vests in 12 equal quarterly installments beginning March 20, 2028, subject to continued service.
• ADS note: Ordinary shares may be represented by ADSs; each ADS represents two ordinary shares; each RSU represents a contingent right to one ordinary share upon settlement.
• Shares owned after the transaction: not specified in this Form 4.
• Filing timeliness: Form filed 2026-09-28 for a 2026-09-24 grant — appears to be later than the typical 2-business-day Form 4 deadline.

Context
RSU grants are common compensation for executives and directors and do not represent an immediate open-market purchase or sale. They vest over time subject to service, so they only convert to actual shares (and potential sellable securities) if and when the vesting conditions are met. This award should be viewed as a compensation grant rather than a direct bullish or bearish trading signal.